First Trust Direct Indexing L.P. boosted its stake in shares of The Cigna Group (NYSE:CI – Free Report) by 7.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,557 shares of the health services provider’s stock after buying an additional 463 shares during the period. First Trust Direct Indexing L.P.’s holdings in The Cigna Group were worth $2,272,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the stock. Cedar Wealth Management LLC purchased a new stake in shares of The Cigna Group during the 1st quarter valued at approximately $29,000. TruNorth Capital Management LLC purchased a new stake in The Cigna Group in the second quarter valued at $33,000. Ulland Investment Advisors LLC lifted its stake in shares of The Cigna Group by 2,500.0% in the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of The Cigna Group during the 2nd quarter worth $66,000. Finally, Private Ocean LLC increased its position in shares of The Cigna Group by 29.9% during the 2nd quarter. Private Ocean LLC now owns 200 shares of the health services provider’s stock worth $66,000 after purchasing an additional 46 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on the stock. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 2nd. Royal Bank of Canada reissued an “outperform” rating and issued a $384.00 target price on shares of The Cigna Group in a research report on Monday, September 9th. Stephens restated an “overweight” rating and set a $410.00 price target on shares of The Cigna Group in a research report on Friday, August 2nd. JPMorgan Chase & Co. boosted their price objective on The Cigna Group from $435.00 to $438.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. Finally, Barclays raised their target price on The Cigna Group from $393.00 to $405.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $392.79.
Insider Buying and Selling
In other The Cigna Group news, Director William J. Delaney III sold 2,691 shares of the firm’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $342.68, for a total transaction of $922,151.88. Following the transaction, the director now owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.60% of the stock is owned by company insiders.
The Cigna Group Stock Up 1.5 %
Shares of NYSE CI opened at $313.00 on Thursday. The Cigna Group has a 1 year low of $253.95 and a 1 year high of $370.83. The company has a market capitalization of $88.92 billion, a price-to-earnings ratio of 25.70, a price-to-earnings-growth ratio of 1.05 and a beta of 0.50. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.71 and a quick ratio of 0.71. The business has a 50-day moving average of $347.15 and a two-hundred day moving average of $341.96.
The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.42 by $0.30. The Cigna Group had a return on equity of 17.83% and a net margin of 1.70%. The firm had revenue of $60.52 billion during the quarter, compared to the consensus estimate of $58.30 billion. During the same period in the prior year, the company posted $6.13 earnings per share. The firm’s quarterly revenue was up 24.6% compared to the same quarter last year. On average, analysts forecast that The Cigna Group will post 28.48 earnings per share for the current fiscal year.
The Cigna Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Investors of record on Wednesday, December 4th will be given a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date of this dividend is Wednesday, December 4th. The Cigna Group’s dividend payout ratio (DPR) is 45.98%.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than The Cigna Group
- How to Invest in the Best Canadian StocksĀ
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How to Use Stock Screeners to Find Stocks
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.